{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Duration of response will be calculated from the date of first evidence of response until the date of progression in the subset of patients with confirmed hematologic responses.","groups":[{"description":"Bortezomib IV on days 1, 8, and 15, oral cyclophosphamide and oral dexamethasone once daily on days 1, 8, 15, and 22.","id":"OG000","title":"Bortez/Cyc/Dex"}],"populationDescription":"Neither participant achieved a response. Therefore, no duration of response calculation was performed.","reportingStatus":"POSTED","timeFrame":"Duration of Study (up to 5 years)","title":"Duration of Response","type":"SECONDARY"}